Holen Sie sich die Stockscreener-App
19.18
0.42%
0.085
Schlusskurs vom Vortag:
$19.09
Offen:
$19.46
24-Stunden-Volumen:
24,901
Relative Volume:
0.45
Marktkapitalisierung:
$171.61M
Einnahmen:
$101.90M
Nettoeinkommen (Verlust:
$-6.41M
KGV:
-4.4153
EPS:
-4.3429
Netto-Cashflow:
$-889.00K
1W Leistung:
+1.59%
1M Leistung:
+1.37%
6M Leistung:
-43.55%
1J Leistung:
-38.26%
1-Tages-Spanne:
$18.91
$19.59
1-Wochen-Bereich:
$18.61
$21.10
52-Wochen-Spanne:
$18.29
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Firmenname
Sanara Medtech Inc
Sektor
Telefon
817-529-2300
Adresse
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
19.21 | 170.58M | 101.90M | -6.41M | -889.00K | -4.3429 |
|
ISRG
Intuitive Surgical Inc
|
474.33 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
160.30 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.12 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
231.46 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.27 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-26 | Bestätigt | H.C. Wainwright | Buy |
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-05-20 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Aktie (SMTI) Neueste Nachrichten
Aug Selloffs: Can Sanara MedTech Inc maintain sales growth2026 Earnings Surprises & High Accuracy Trade Alerts - baoquankhu1.vn
Sanara MedTech study shows cost savings with CellerateRX powder - Investing.com India
Sanara MedTech Inc. Announces Publication of Peer-Reviewed - GlobeNewswire
Sanara MedTech study shows cost savings with CellerateRX powder By Investing.com - Investing.com Nigeria
Sanara MedTech (SMTI) Study Highlights Cost-Effectiveness of Cel - GuruFocus
Spine surgery wounds: CellerateRX study finds $3,852 saved per patient - Stock Titan
(SMTI) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Merger Talk: Can Sanara MedTech Inc navigate macro headwindsWeekly Investment Summary & Daily Momentum Trading Reports - baoquankhu1.vn
Valuation Update: Is Sanara MedTech Inc undervalued by DCF analysisRecession Risk & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - marketscreener.com
Sanara MedTech (SMTI) CEO has 491 shares withheld to cover tax on vesting - Stock Titan
Sanara MedTech Unveils 2026 Strategy in Investor Presentation - TipRanks
Sanara MedTech (NASDAQ: SMTI) furnishes 2026 outlook deck - Stock Titan
SMTI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SMTI Should I Buy - Intellectia AI
SMTI PE Ratio & Valuation, Is SMTI Overvalued - Intellectia AI
Sanara MedTech (SMTI) COO has shares withheld to cover taxes - Stock Titan
Sanara MedTech (SMTI) CFO uses 437 shares to cover tax withholding - Stock Titan
Sanara MedTech (SMTI) Controller has 149 shares withheld for taxes - Stock Titan
(SMTI) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Reviewing Koninklijke Philips (NYSE:PHG) and Sanara MedTech (NASDAQ:SMTI) - Defense World
Patterns Watch: Whats next for Sanara MedTech Inc stockMarket Weekly Review & Weekly High Momentum Picks - baoquankhu1.vn
SMTI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sanara MedTech Inc. (SMTI) Stock Analysis: Unpacking a 103.56% Potential Upside for Investors - DirectorsTalk Interviews
Sanara MedTech (NASDAQ:SMTI) Shares Up 2.9%Time to Buy? - MarketBeat
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd - Bitget
Sanara MedTech Inc. to Present at TD Cowen 46th Annual Health Care Conference - Quiver Quantitative
Why Sanara MedTech Inc. stock is a must watch in 2025July 2025 Trends & Daily Stock Trend Reports - mfd.ru
(SMTI) Risk Channels and Responsive Allocation - Stock Traders Daily
What is Sanara MedTech Inc. s 5 year growth outlookShare Buyback & Weekly Stock Performance Updates - mfd.ru
Will Sanara MedTech Inc. stock see insider buyingIPO Watch & Stepwise Entry/Exit Trade Alerts - mfd.ru
Is Sanara MedTech Inc. undervalued by DCF analysisRate Cut & Real-Time Price Movement Reports - mfd.ru
Shareholders in Sanara MedTech (NASDAQ:SMTI) are in the red if they invested three years ago - Yahoo Finance
Can Sanara MedTech Inc. deliver consistent dividends2025 Market WrapUp & Reliable Entry Point Trade Alerts - mfd.ru
What margin trends mean for Sanara MedTech Inc. stockTrade Entry Report & Weekly Stock Performance Updates - mfd.ru
Will Sanara MedTech Inc. stock deliver shareholder valueWeekly Stock Recap & Long-Term Growth Stock Strategies - mfd.ru
Sanara Medtech's Growth Trajectory Gains Momentum Amid Strategic Shift () - aktiencheck.de
(SMTI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Sanara MedTech’s Stock Under the Microscope: Niche Wound-Care Player Tests Investor Patience - AD HOC NEWS
Stop Loss: Is FNGS in a consolidation phasePortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn
HC Wainwright Predicts Weaker Earnings for Sanara MedTech - MarketBeat
Analysts Issue Forecasts for Sanara MedTech FY2025 Earnings - Defense World
Sanara MedTech FY2025 EPS Forecast Boosted by HC Wainwright - MarketBeat
SMTI Latest Analyst Rating Update: HC Wainwright & Co. Reiterates Buy | SMTI Stock News - GuruFocus
Sanara MedTech (NASDAQ:SMTI) Receives “Buy” Rating from HC Wainwright - Defense World
HC Wainwright Reiterates Buy Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Liquidity Mapping Around (SMTI) Price Events - Stock Traders Daily
Can Sanara MedTech Inc. stock outperform in a bear marketJuly 2025 Outlook & Capital Efficiency Focused Strategies - mfd.ru
Sanara MedTech expects 19% revenue growth for 2025, issues 2026 guidance - Investing.com Nigeria
Sanara MedTech reports Q4 preliminary net revenue $27.2M-$27.7M - TipRanks
SMTI Projects Revenue Growth for Q4 and Secures New Contract - GuruFocus
Finanzdaten der Sanara Medtech Inc-Aktie (SMTI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.17%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):